Sun, Apr 20, 2014, 1:55 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • burnaka@sbcglobal.net burnaka May 8, 2013 4:01 PM Flag

    The foresight goggles have been discontinued they did not work very well

    Hind sight goggles work like a charm.. One observation with OPK in hind site is the market either does not like the pbth deal, or has concern with the ambulance chasing lawyers. The recent weakness corresponds with the announced deal. This could be hedgies going long pbth, and shorting opk, not sure.

    The current price in HIND SITE may be viewed as a great buying or covering opportunity as PBTH situation clears up. Using the foggy Foresight goggles I see OPK as a highly profitable company with near a billion in revenue in the next couple years. Opk is just getting started and will gain momentum on revenue and earnings in q3 and q4, the stock will be a teenager in 2014.

    Breaking news in a biotech can be predicted by the number of near completed phase 3 projects, so we have no near term catalysts. We do have 4k launch which is gaining slow but steady traction in England, how it is accepted here, we will see. Should replace PSA but that would be using Foresight glasses.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OPK
8.14-0.19(-2.28%)Apr 17 4:04 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST